uniQure (QURE) Operating Leases (2019 - 2026)
uniQure's (QURE) quarterly Operating Leases came in at $10.4 million in Q1 2026, down 4.75% year-on-year from $10.9 million in Q1 2025, and up 5.66% quarter-over-quarter from $9.8 million in Q4 2025.
uniQure (QURE) Operating Leases (2019 - 2026) Analysis & Trends
uniQure's Operating Leases history runs 8 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- On a quarterly basis, Operating Leases fell 4.75% year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $10.4 million, a 4.75% decrease from a year earlier, with the FY2025 full-year figure at $9.8 million, down 11.71% from the prior year.
- Operating Leases improved to $10.4 million in Q1 2026 per QURE's latest filing, from $9.8 million in the prior quarter.
- Across five years, Operating Leases topped out at $36.7 million in Q4 2023 and bottomed at $9.8 million in Q4 2025.
- The 5-year median for Operating Leases is $27.0 million (2024), against an average of $21.3 million.
- Across the five-year window, Operating Leases climbed 15.58% in 2023 and plunged 69.62% in 2024, its largest moves.
- Year by year, Operating Leases stood at $31.7 million in 2022, then advanced by 15.58% to $36.7 million in 2023, then plunged by 69.62% to $11.1 million in 2024, then decreased by 11.71% to $9.8 million in 2025, then advanced by 5.66% to $10.4 million in 2026.
- Per Business Quant, the three latest QURE Operating Leases figures stand at $10.4 million (Q1 2026), $9.8 million (Q4 2025), and $10.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.39 Mn |
| Dec 31, 2025 | 9.83 Mn |
| Sep 30, 2025 | 10.36 Mn |
| Jun 30, 2025 | 10.95 Mn |
| Mar 31, 2025 | 10.91 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 12.19 Mn |
| Jun 30, 2024 | 12.37 Mn |
| Mar 31, 2024 | 26.98 Mn |
| Dec 31, 2023 | 36.66 Mn |
| Sep 30, 2023 | 28.98 Mn |
| Jun 30, 2023 | 30.20 Mn |
| Mar 31, 2023 | 31.08 Mn |
| Dec 31, 2022 | 31.72 Mn |
| Sep 30, 2022 | 29.89 Mn |
| Jun 30, 2022 | 30.72 Mn |
| Mar 31, 2022 | 28.23 Mn |
| Dec 31, 2021 | 28.99 Mn |
| Sep 30, 2021 | 29.73 Mn |
| Jun 30, 2021 | 30.53 Mn |